 |
2-(2-chlorobenzylidene)hydrazinecarboximidamide acetate |
|---|---|
| Trade Name | |
| Orphan Indication | Charcot-Marie-Tooth disease |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-10 00:00:00 |
| Sponsor | InFlectis BioScience;21 rue de la Noue Bras de Fer, 44200 Nantes; |
